Non Us — Net Sales
Boston Scientific Non Us — Net Sales increased by 7.4% to $1.90B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.9%, from $1.67B to $1.90B. Over 4 years (FY 2021 to FY 2025), Non Us — Net Sales shows an upward trend with a 9.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful international market expansion, strong global demand for the company's product portfolio, or effective local distribution strategies. A decrease may signal increased international competition, regulatory hurdles, or unfavorable currency exchange rate impacts.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and related services within internat...
Peer comparison
Peers in the medical device industry typically report international revenue as a percentage of total sales to demonstrate global diversification and exposure to emerging market growth rates.
bsx_segment_int_l_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.28B | $1.21B | $1.33B | $1.25B | $1.31B | $1.24B | $1.32B | $1.39B | $1.49B | $1.43B | $1.51B | $1.60B | $1.65B | $1.62B | $1.67B | $1.70B | $1.84B | $1.77B | $1.90B |
| QoQ Change | — | -5.6% | +10.2% | -6.1% | +5.0% | -5.7% | +6.5% | +5.3% | +7.5% | -4.2% | +6.0% | +5.7% | +3.4% | -2.3% | +3.3% | +2.0% | +7.9% | -3.6% | +7.4% |
| YoY Change | — | — | — | — | +2.7% | +2.5% | -1.0% | +11.1% | +13.7% | +15.5% | +15.0% | +15.4% | +11.0% | +13.2% | +10.3% | +6.4% | +11.1% | +9.5% | +13.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's non us — net sales?
- Boston Scientific (BSX) reported non us — net sales of $1.90B in Q4 2025.
- How has Boston Scientific's non us — net sales changed year-over-year?
- Boston Scientific's non us — net sales increased by 13.9% year-over-year, from $1.67B to $1.90B.
- What is the long-term trend for Boston Scientific's non us — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's non us — net sales has grown at a 9.7% compound annual growth rate (CAGR), from $4.98B to $7.21B.
- What does non us — net sales mean?
- The total revenue earned from medical device sales in all geographic regions outside the company's home country.